GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above - PRNewswire

GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above  PRNewswire

LONDON and PHILADELPHIA, April 26, 2019 /PRNewswire/ -- GSK today announced that the US Food and Drug Administration (FDA) has approved, under ...